Follow-up study reports efficacy and toxicity of peptide receptor radionuclide therapy in advanced refractory meningiomas, highlighting a potential targeted theranostic approach.
Recurrence of meningiomas after surgery and radiotherapy deserves specific attention because of the lack of active third-line therapies. Somatostatin receptors are usually overexpressed on the cell membrane of meningiomas, and this has led the way to a radionuclide theranostic approach. Diagnoses with
No takes yet. Share an insight, caveat, or question.
Severi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: